Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
29 /100
MEDIUM RISK
Score updated Oct 13, 2026

NAGE — Niagen Bioscience, Inc. Dilution Risk Tracker

Track NAGE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NAGE — Get alerts when the score changes →

As of October 13, 2026, Niagen Bioscience, Inc. (NAGE) has a DilutionWatch DilutionScore of 29/100, rated MEDIUM dilution risk. Niagen Bioscience, Inc. has a market capitalization of $208.10M, 79.13M shares outstanding, 147 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰Cash Runway—
📊 Float Risk
20
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for NAGE.
🔔 Track NAGE — Get forecast alerts →

Market Data

Market Cap$208.10M
Shares Outstanding79.13M
Float59.57M
Cash$64.10M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore29/100DilutionWatch score record
Shares Outstanding79.13MVerified float table or market cache
Public Float59.57MVerified float table or market cache
Market Cap$208.10MMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 29.9% shares (2026Q1 vs prior)
147 institutional holders · 42.67M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 4.30M shares
#2 BlackRock, Inc. 3.87M shares
#3 SteelPeak Wealth, LLC 3.37M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.87M
Days to Cover9.9
% of Float6.5%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-03-12
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NAGE Dilution Snapshot

Niagen Bioscience, Inc. (NAGE) has a DilutionScore of 29/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NAGE's DilutionScore is currently 29/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 33/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202629/100MEDIUM53 days
Aug 14 – Aug 21, 202633/100MEDIUM7 days
Jul 16 – Aug 13, 202629/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NAGE shares outstanding have decreased 0.2% from 79.81M (Mar 2026) to 79.64M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 27, 202679.64M59.57M▼ 0.05%
May 25, 202679.64M59.60M▲ 13.68%
May 15, 202679.64M52.43M▲ 0.12%
May 11, 202679.64M52.37M▼ 0.19%
May 09, 202679.64M52.47M▼ 0.75%
May 01, 202679.64M52.87M▼ 0.04%
Mar 08, 202679.81M52.89M▲ 0.10%
Mar 07, 202679.81M52.83M▲ 0.21%
Mar 05, 202679.81M52.72M▼ 0.01%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NAGE Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NAGE files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NAGE — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NAGE
NAGE FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.